{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T14:04:21Z","timestamp":1769263461365,"version":"3.49.0"},"reference-count":245,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:00:00Z","timestamp":1594684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.01660","type":"journal-article","created":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T06:42:46Z","timestamp":1594708966000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":55,"title":["High-Dose Intravenous Immunoglobulins in the Treatment of Severe Acute Viral Pneumonia: The Known Mechanisms and Clinical Effects"],"prefix":"10.3389","volume":"11","author":[{"given":"Xiaosheng","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taisheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,7,14]]},"reference":[{"key":"B1","unstructured":"32264957Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19).2020"},{"key":"B2","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.18433\/jpps31002","article-title":"Current drugs with potential for treatment of COVID-19: a literature review","volume":"23","author":"Md Insiat Islam","year":"2020","journal-title":"J Pharm Pharm Sci."},{"key":"B4","unstructured":"Diagnosis and Treatment of Pneumonia Infected by Novel Coronavirus (Trial Version 7).2020"},{"key":"B5","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S0140-6736(20)30317-2","article-title":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury","volume":"395","author":"Russell","year":"2020","journal-title":"Lancet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1055\/s-0040-1709684","article-title":"Corticosteroid guidance for pregnancy during COVID-19 pandemic","volume":"37","author":"McIntosh","year":"2020","journal-title":"Am J Perinatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.medj.2020.06.001","article-title":"Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid19","author":"Magagnoli","year":"","journal-title":"Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"m1849","DOI":"10.1136\/bmj.m1849","article-title":"Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial","volume":"369","author":"Tang","year":"2020","journal-title":"BMJ."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.17.20037432","article-title":"Favipiravir versus arbidol for COVID-19: a randomized clinical trial","author":"Chen","year":"2020","journal-title":"medRxiv [Preprint]."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1056\/NEJMc2008043","article-title":"A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N Engl J Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s00281-016-0558-0","article-title":"The host immune response in respiratory virus infection: balancing virus clearance and immunopathology","volume":"38","author":"Newton","year":"2016","journal-title":"Semin Immunopathol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41577-020-0305-6","article-title":"In the eye of the COVID-19 cytokine storm","volume":"20","author":"Vaninov","year":"2020","journal-title":"Nat Rev Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"108393","DOI":"10.1016\/j.clim.2020.108393","article-title":"The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China","volume":"214","author":"Zhang","year":"2020","journal-title":"Clin Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.antiviral.2018.01.002","article-title":"The role of adjuvant immunomodulatory agents for treatment of severe influenza","volume":"150","author":"Hui","year":"2018","journal-title":"Antiviral Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"ofaa102","DOI":"10.1093\/ofid\/ofaa102","article-title":"High-dose intravenous immunoglobulin as a therapeutic option for deteriorating patients with Coronavirus Disease 2019","volume":"7","author":"Cao","year":"2020","journal-title":"Open Forum Infect Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1080\/22221751.2020.1746199","article-title":"Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia","volume":"9","author":"Lin","year":"2020","journal-title":"Emerg Microbes Infect."},{"key":"B18","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1080\/22221751.2020.1735265","article-title":"Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0)","volume":"9","author":"Li","year":"2020","journal-title":"Emerg Microbes Infect."},{"key":"B19","doi-asserted-by":"publisher","first-page":"629","DOI":"10.3389\/fimmu.2014.00629","article-title":"Is dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in europe.","volume":"5","author":"Kerr","year":"2014","journal-title":"Front Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s12016-009-8155-9","article-title":"Evidence for the use of intravenous immunoglobulins\u2013a review of the literature","volume":"38","author":"Kivity","year":"2010","journal-title":"Clin Rev Allergy Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"15825","DOI":"10.1038\/srep15825","article-title":"Identification of the Streptococcus pyogenes surface antigens recognised by pooled human immunoglobulin","volume":"5","author":"Reglinski","year":"2015","journal-title":"Sci Rep."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1128\/CDLI.11.6.1158-1164.2004","article-title":"Characterization of antibodies to capsular polysaccharide antigens of Haemophilus influenzae type b and Streptococcus pneumoniae in human immune globulin intravenous preparations","volume":"11","author":"Mikolajczyk","year":"2004","journal-title":"Clin Diagn Lab Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"357ra124","DOI":"10.1126\/scitranslmed.aag1153","article-title":"IVIG-mediated protection against necrotizing pneumonia caused by MRSA.","volume":"8","author":"Diep","year":"2016","journal-title":"Sci Transl Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s10096-013-1861-5","article-title":"Assessment of the efficacy of polyclonal intravenous immunoglobulin G (IVIG) against the infectivity of clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) in vitro and in vivo","volume":"32","author":"Farag","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s13104-019-4262-8","article-title":"Treatment potential of pathogen-reactive antibodies sequentially purified from pooled human immunoglobulin","volume":"12","author":"Reglinski","year":"2019","journal-title":"BMC Res Notes."},{"key":"B26","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jcv.2017.03.005","article-title":"Comparison of cytomegalovirus (CMV)-specific neutralization capacity of hyperimmunoglobulin (HIG) versus standard intravenous immunoglobulin (IVIG) preparations: impact of CMV IgG normalization","volume":"90","author":"Schampera","year":"2017","journal-title":"J Clin Virol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1086\/507037","article-title":"Different preparations of intravenous immunoglobulin vary in their efficacy to neutralize streptococcal superantigens: implications for treatment of streptococcal toxic shock syndrome","volume":"43","author":"Schrage","year":"2006","journal-title":"Clin Infect Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e00968","DOI":"10.1128\/AAC.00968-17","article-title":"Commercial intravenous immunoglobulin preparations contain functional neutralizing antibodies against the Staphylococcus aureus leukocidin LukAB (LukGH)","volume":"61","author":"Wood","year":"2017","journal-title":"Antimicrob Agents Chemother."},{"key":"B29","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jpba.2018.01.021","article-title":"In vitro evaluation of the biological activities of IgG in seven Chinese intravenous immunoglobulin preparations","volume":"151","author":"Ye","year":"2018","journal-title":"J Pharm Biomed Anal."},{"key":"B30","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1046\/j.1365-2567.2000.00949.x","article-title":"Neutralizing antibodies to granulocyte-macrophage colony-stimulating factor, interleukin-1alpha and interferon-alpha but not other cytokines in human immunoglobulin preparations","volume":"99","author":"Wadhwa","year":"2000","journal-title":"Immunology."},{"key":"B31","doi-asserted-by":"publisher","first-page":"7606","DOI":"10.4049\/jimmunol.166.12.7606","article-title":"Antibodies to C-C chemokine receptor 5 in normal human IgG block infection of macrophages and lymphocytes with primary R5-tropic strains of HIV-1","volume":"166","author":"Bouhlal","year":"2001","journal-title":"J Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.jaci.2007.01.023","article-title":"Intravenous immunoglobulin preparations contain anti-Siglec-8 autoantibodies","volume":"119","author":"von Gunten","year":"2007","journal-title":"J Allergy Clin Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1111\/j.1398-9995.2011.02579.x","article-title":"Dimeric IVIG contains natural anti-Siglec-9 autoantibodies and their anti-idiotypes","volume":"66","author":"Schaub","year":"2011","journal-title":"Allergy."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.jaci.2003.09.045","article-title":"Concurrent presence of agonistic and antagonistic anti-CD95 autoantibodies in intravenous Ig preparations","volume":"112","author":"Altznauer","year":"2003","journal-title":"J Allergy Clin Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1126\/science.282.5388.490","article-title":"Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin","volume":"282","author":"Viard","year":"1998","journal-title":"Science."},{"key":"B36","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s10875-007-9082-2","article-title":"BAFF, a new target for intravenous immunoglobulin in autoimmunity and cancer","volume":"27","author":"Le Pottier","year":"2007","journal-title":"J Clin Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1196\/annals.1423.044","article-title":"Intravenous immunoglobulin and cytokines: focus on tumor necrosis factor family members BAFF and APRIL.","volume":"1110","author":"Le Pottier","year":"2007","journal-title":"Ann N Y Acad Sci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3109\/08916934.2014.983265","article-title":"Abeta anti-idiotypic antibodies are present in intravenous immunoglobulin and are produced in mice following its administration","volume":"48","author":"Loeffler","year":"2015","journal-title":"Autoimmunity."},{"key":"B39","doi-asserted-by":"publisher","first-page":"35s","DOI":"10.1016\/S0002-9343(91)80147-E","article-title":"Intravenous immunoglobulin in the treatment of spontaneously acquired factor VIII:C inhibitors","volume":"91","author":"Sultan","year":"1991","journal-title":"Am J Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nm836","article-title":"F(ab)\u20322-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins","volume":"9","author":"Basta","year":"2003","journal-title":"Nat Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"637","DOI":"10.2174\/1567205011666140812113707","article-title":"Role of complement systems in IVIG mediated attenuation of cognitive deterioration in Alzheimer's disease","volume":"11","author":"Gong","year":"2014","journal-title":"Curr Alzheimer Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/0140-6736(93)92000-J","article-title":"Infusion of Fc gamma fragments for treatment of children with acute immune thrombocytopenic purpura","volume":"342","author":"Debre","year":"1993","journal-title":"Lancet."},{"key":"B43","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1126\/science.291.5503.484","article-title":"Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor","volume":"291","author":"Samuelsson","year":"2001","journal-title":"Science."},{"key":"B44","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1126\/science.1129594","article-title":"Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation","volume":"313","author":"Kaneko","year":"2006","journal-title":"Science."},{"key":"B45","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1182\/blood-2011-08-376046","article-title":"IgG1 and IVIg induce inhibitory ITAM signaling through FcgammaRIII controlling inflammatory responses","volume":"119","author":"Aloulou","year":"2012","journal-title":"Blood."},{"key":"B46","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1182\/blood-2008-09-179754","article-title":"Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses","volume":"113","author":"Bruhns","year":"2009","journal-title":"Blood."},{"key":"B47","doi-asserted-by":"publisher","first-page":"332","DOI":"10.4049\/jimmunol.173.1.332","article-title":"Monomeric IgG in intravenous Ig preparations is a functional antagonist of FcgammaRII and FcgammaRIIIb","volume":"173","author":"van Mirre","year":"2004","journal-title":"J Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1182\/blood.V98.4.1095","article-title":"Therapeutic efficacy of intravenous immunoglobulin preparations depends on the immunoglobulin G dimers: studies in experimental immune thrombocytopenia","volume":"98","author":"Teeling","year":"2001","journal-title":"Blood."},{"key":"B49","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/BF00320302","article-title":"Are aggregates of IgG the effective part of high-dose immunoglobulin therapy in adult idiopathic thrombocytopenic purpura (ITP)?","volume":"50","author":"Augener","year":"1985","journal-title":"Blut."},{"key":"B50","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1007\/s11481-019-09871-0","article-title":"Changes of serum IgG dimer levels after treatment with IVIg in Guillain-Barre syndrome","volume":"14","author":"Svacina","year":"2019","journal-title":"J Neuroimmune Pharmacol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12974-015-0361-1","article-title":"Chronic inflammatory demyelinating polyneuropathy (CIDP): change of serum IgG dimer levels during treatment with intravenous immunoglobulins","volume":"12","author":"Ritter","year":"2015","journal-title":"J Neuroinflammation."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1080\/19420862.2019.1633883","article-title":"Antibody Fc engineering for enhanced neonatal Fc receptor binding and prolonged circulation half-life","volume":"11","author":"Mackness","year":"2019","journal-title":"MAbs."},{"key":"B53","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/nri2155","article-title":"FcRn: the neonatal Fc receptor comes of age","volume":"7","author":"Roopenian","year":"2007","journal-title":"Nat Rev Immunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1055\/s-0037-1613331","article-title":"Intravenous immunoglobulin mediates an increase in anti-platelet antibody clearance via the FcRn receptor","volume":"88","author":"Hansen","year":"2002","journal-title":"Thromb Haemost."},{"key":"B55","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1172\/JCI24394","article-title":"Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases","volume":"115","author":"Li","year":"2005","journal-title":"J Clin Invest."},{"key":"B56","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/cei.12529","article-title":"Influence of FCRN expression on lung decline and intravenous immunoglobulin catabolism in common variable immunodeficiency patients","volume":"178","author":"Litzman","year":"2014","journal-title":"Clin Exp Immunol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"614","DOI":"10.4161\/mabs.24815","article-title":"Influence of FCGRT gene polymorphisms on pharmacokinetics of therapeutic antibodies","volume":"5","author":"Passot","year":"2013","journal-title":"MAbs."},{"key":"B58","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/cei.12002","article-title":"Efficiency of immunoglobulin G replacement therapy in common variable immunodeficiency: correlations with clinical phenotype and polymorphism of the neonatal Fc receptor","volume":"171","author":"Gouilleux-Gruart","year":"2013","journal-title":"Clin Exp Immunol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"282989","DOI":"10.1155\/2012\/282989","article-title":"Pharmacokinetic models for FcRn-mediated IgG disposition","volume":"2012","author":"Xiao","year":"2012","journal-title":"J Biomed Biotechnol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/379346a0","article-title":"Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice","volume":"379","author":"Takai","year":"1996","journal-title":"Nature."},{"key":"B61","doi-asserted-by":"publisher","first-page":"4788","DOI":"10.1073\/pnas.0807319106","article-title":"Impaired inhibitory Fcgamma receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy","volume":"106","author":"Tackenberg","year":"2009","journal-title":"Proc Natl Acad Sci USA."},{"key":"B62","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1126\/science.1154315","article-title":"Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc","volume":"320","author":"Anthony","year":"2008","journal-title":"Science."},{"key":"B63","doi-asserted-by":"publisher","first-page":"19571","DOI":"10.1073\/pnas.0810163105","article-title":"Identification of a receptor required for the anti-inflammatory activity of IVIG","volume":"105","author":"Anthony","year":"2008","journal-title":"Proc Natl Acad Sci USA."},{"key":"B64","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature10134","article-title":"Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway","volume":"475","author":"Anthony","year":"2011","journal-title":"Nature."},{"key":"B65","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/nri3401","article-title":"Intravenous immunoglobulin therapy: how does IgG modulate the immune system?","volume":"13","author":"Schwab","year":"2013","journal-title":"Nat Rev Immunol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.jmb.2013.02.006","article-title":"Dissecting the molecular mechanism of IVIg therapy: the interaction between serum IgG and DC-SIGN is independent of antibody glycoform or Fc domain","volume":"425","author":"Yu","year":"2013","journal-title":"J Mol Biol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"9995","DOI":"10.1038\/s41598-019-46484-2","article-title":"Human DC-SIGN and CD23 do not interact with human IgG.","volume":"9","author":"Temming","year":"2019","journal-title":"Sci Rep."},{"key":"B68","doi-asserted-by":"publisher","first-page":"E25","DOI":"10.1073\/pnas.0900016106","article-title":"DC-SIGN and alpha2,6-sialylated IgG Fc interaction is dispensable for the anti-inflammatory activity of IVIg on human dendritic cells","volume":"106","author":"Bayry","year":"2009","journal-title":"Proc Natl Acad Sci USA."},{"key":"B69","doi-asserted-by":"publisher","first-page":"e37243","DOI":"10.1371\/journal.pone.0037243","article-title":"Analysis and functional consequences of increased Fab-sialylation of intravenous immunoglobulin (IVIG) after lectin fractionation","volume":"7","author":"Kasermann","year":"2012","journal-title":"PLoS ONE."},{"key":"B70","doi-asserted-by":"publisher","first-page":"5031","DOI":"10.4049\/jimmunol.1301611","article-title":"Therapeutic effect of IVIG on inflammatory arthritis in mice is dependent on the Fc portion and independent of sialylation or basophils","volume":"192","author":"Campbell","year":"2014","journal-title":"J Immunol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.1182\/blood-2014-05-576835","article-title":"Inhibition of FcgammaR-mediated phagocytosis by IVIg is independent of IgG-Fc sialylation and FcgammaRIIb in human macrophages","volume":"124","author":"Nagelkerke","year":"2014","journal-title":"Blood."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1111\/j.1537-2995.2011.03517.x","article-title":"Sialylation-independent mechanism involved in the amelioration of murine immune thrombocytopenia using intravenous gammaglobulin","volume":"52","author":"Leontyev","year":"2012","journal-title":"Transfusion."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1172\/JCI117520","article-title":"High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments","volume":"94","author":"Basta","year":"1994","journal-title":"J Clin Invest."},{"key":"B74","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1182\/blood-2003-05-1530","article-title":"Intravenously applied IgG stimulates complement attenuation in a complement-dependent autoimmune disease at the amplifying C3 convertase level","volume":"103","author":"Lutz","year":"2004","journal-title":"Blood."},{"key":"B75","doi-asserted-by":"publisher","first-page":"14104","DOI":"10.1073\/pnas.0700506104","article-title":"Intravenous immunoglobulin (IVIG) protects the brain against experimental stroke by preventing complement-mediated neuronal cell death","volume":"104","author":"Arumugam","year":"2007","journal-title":"Proc Natl Acad Sci USA."},{"key":"B76","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1385\/IR:22:2-3:137","article-title":"Immunoglobulin in the control of complement action","volume":"22","author":"Frank","year":"2000","journal-title":"Immunol Res."},{"key":"B77","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/332738a0","article-title":"The binding site for C1q on IgG.","volume":"332","author":"Duncan","year":"1988","journal-title":"Nature."},{"key":"B78","doi-asserted-by":"publisher","first-page":"646","DOI":"10.3389\/fimmu.2017.00646","article-title":"Fc-Galactosylation of human immunoglobulin gamma isotypes improves C1q binding and enhances complement-dependent cytotoxicity","volume":"8","author":"Peschke","year":"2017","journal-title":"Front Immunol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2020.04.007","article-title":"Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases","volume":"220","author":"Magro","year":"2020","journal-title":"Transl Res"},{"key":"B81","doi-asserted-by":"publisher","first-page":"E005","DOI":"10.3760\/cma.j.issn.0578-1310.2020.0005","article-title":"[First case of critical novel coronavirus pneumonia in Chinese children]","volume":"58","author":"Chen","year":"2020","journal-title":"Zhonghua Er Ke Za Zhi."},{"key":"B82","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/path.1440","article-title":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China","volume":"200","author":"Ding","year":"2003","journal-title":"J Pathol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1002\/path.1597","article-title":"Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS-CoV) and its putative receptor, angiotensin-converting enzyme 2 (ACE2)","volume":"203","author":"To","year":"2004","journal-title":"J Pathol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jmv.20407","article-title":"Autoantibodies against human epithelial cells and endothelial cells after severe acute respiratory syndrome (SARS)-associated coronavirus infection","volume":"77","author":"Yang","year":"2005","journal-title":"J Med Virol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.cell.2011.08.015","article-title":"Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection","volume":"146","author":"Teijaro","year":"2011","journal-title":"Cell."},{"key":"B86","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1086\/656044","article-title":"Influenza virus-cytokine-protease cycle in the pathogenesis of vascular hyperpermeability in severe influenza","volume":"202","author":"Wang","year":"2010","journal-title":"J Infect Dis."},{"key":"B87","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3389\/fmicb.2014.00653","article-title":"Influenza virus and endothelial cells: a species specific relationship","volume":"5","author":"Short","year":"2014","journal-title":"Front Microbiol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1002\/eji.201242398","article-title":"Anti-inflammatory effects of high-dose IgG on TNF-alpha-activated human coronary artery endothelial cells","volume":"42","author":"Matsuda","year":"2012","journal-title":"Eur J Immunol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00210-006-0084-z","article-title":"Anti-inflammatory effect of intravenous immunoglobulin in comparison with dexamethasone in vitro: implication for treatment of Kawasaki disease","volume":"373","author":"Makata","year":"2006","journal-title":"Naunyn Schmiedebergs Arch Pharmacol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/j.1365-2249.2004.02496.x","article-title":"Effect of maternal anti-HPA-1a antibodies and polyclonal IVIG on the activation status of vascular endothelial cells","volume":"137","author":"Radder","year":"2004","journal-title":"Clin Exp Immunol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/nature03464","article-title":"IRF-7 is the master regulator of type-I interferon-dependent immune responses","volume":"434","author":"Honda","year":"2005","journal-title":"Nature."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/nature03547","article-title":"Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction","volume":"434","author":"Honda","year":"2005","journal-title":"Nature."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-CoV-2 drives development of COVID-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell."},{"key":"B94","doi-asserted-by":"publisher","first-page":"9812","DOI":"10.1128\/JVI.01012-07","article-title":"Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum\/Golgi membrane","volume":"81","author":"Frieman","year":"2007","journal-title":"J Virol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"4471","DOI":"10.1128\/JVI.02472-07","article-title":"Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells","volume":"82","author":"Narayanan","year":"2008","journal-title":"J Virol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"e30802","DOI":"10.1371\/journal.pone.0030802","article-title":"Coronavirus papain-like proteases negatively regulate antiviral innate immune response through disruption of STING-mediated signaling","volume":"7","author":"Sun","year":"2012","journal-title":"PLoS ONE."},{"key":"B97","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1128\/JVI.01782-06","article-title":"Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists","volume":"81","author":"Kopecky-Bromberg","year":"2007","journal-title":"J Virol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"e00665","DOI":"10.1128\/mBio.00665-17","article-title":"MERS-CoV accessory ORFs play key role for infection and pathogenesis","volume":"8","author":"Menachery","year":"2017","journal-title":"mBio."},{"key":"B99","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1128\/JVI.03607-14","article-title":"High secretion of interferons by human plasmacytoid dendritic cells upon recognition of Middle East respiratory syndrome coronavirus","volume":"89","author":"Scheuplein","year":"2015","journal-title":"J Virol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1182\/blood-2006-05-023770","article-title":"Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon","volume":"109","author":"Cervantes-Barragan","year":"2007","journal-title":"Blood."},{"key":"B101","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.chom.2016.01.007","article-title":"Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice","volume":"19","author":"Channappanavar","year":"2016","journal-title":"Cell Host Microbe."},{"key":"B102","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3109\/08923973.2013.864668","article-title":"Dose-related regulatory effect of intravenous immunoglobulin on dendritic cells-mediated immune response","volume":"36","author":"Qian","year":"2014","journal-title":"Immunopharmacol Immunotoxicol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1182\/blood-2002-05-1447","article-title":"Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin","volume":"101","author":"Bayry","year":"2003","journal-title":"Blood."},{"key":"B104","doi-asserted-by":"publisher","first-page":"5625","DOI":"10.4049\/jimmunol.1301260","article-title":"Intravenous immunoglobulin treatment in humans suppresses dendritic cell function via stimulation of IL-4 and IL-13 production","volume":"192","author":"Tjon","year":"2014","journal-title":"J Immunol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.jaci.2013.09.029","article-title":"Dendritic cell immunoreceptor: a novel receptor for intravenous immunoglobulin mediates induction of regulatory T cells","volume":"133","author":"Massoud","year":"2014","journal-title":"J Allergy Clin Immunol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jaut.2012.05.013","article-title":"Effect of IVIg on human dendritic cell-mediated antigen uptake and presentation: role of lipid accumulation","volume":"39","author":"Othy","year":"2012","journal-title":"J Autoimmun."},{"key":"B107","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1097\/01.tp.0000226073.20185.b1","article-title":"Superior immunomodulatory effects of intravenous immunoglobulins on human T-cells and dendritic cells: comparison to calcineurin inhibitors","volume":"81","author":"Tha-In","year":"2006","journal-title":"Transplantation."},{"key":"B108","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.chom.2020.04.009","article-title":"Complex immune dysregulation in COVID-19 patients with severe respiratory failure","volume":"27","author":"Giamarellos-Bourboulis","year":"2020","journal-title":"Cell Host Microbe"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.27.20045427","article-title":"The novel severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) directly decimates human spleens and lymph nodes","author":"Chen","year":"2020","journal-title":"medRxiv [Preprint]"},{"key":"B110","doi-asserted-by":"publisher","first-page":"e123158","DOI":"10.1172\/jci.insight.123158","article-title":"Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection","volume":"4","author":"Liu","year":"2019","journal-title":"JCI Insight."},{"key":"B111","doi-asserted-by":"publisher","first-page":"7819","DOI":"10.1128\/JVI.79.12.7819-7826.2005","article-title":"Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis","volume":"79","author":"Cheung","year":"2005","journal-title":"J Virol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.virusres.2007.02.007","article-title":"Up-regulation of IL-6 and TNF-alpha induced by SARS-coronavirus spike protein in murine macrophages via NF-kappaB pathway","volume":"128","author":"Wang","year":"2007","journal-title":"Virus Res."},{"key":"B113","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.virusres.2009.01.005","article-title":"SARS coronavirus spike protein-induced innate immune response occurs via activation of the NF-kappaB pathway in human monocyte macrophages in vitro","volume":"142","author":"Dosch","year":"2009","journal-title":"Virus Res."},{"key":"B114","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1054\/blre.1999.0121","article-title":"Monocyte-macrophage system as targets for immunomodulation by intravenous immunoglobulin","volume":"14","author":"Rhoades","year":"2000","journal-title":"Blood Rev."},{"key":"B115","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10067-017-3625-6","article-title":"Macrophage activation syndrome in systemic lupus erythematosus: a multicenter, case-control study in China","volume":"37","author":"Liu","year":"2018","journal-title":"Clin Rheumatol."},{"key":"B116","first-page":"996","article-title":"[Clinical characteristics and treatment outcomes of macrophage activation syndrome in adults: a case series of 67 patients]","volume":"51","author":"Yao","year":"2019","journal-title":"Beijing Da Xue Xue Bao Yi Xue Ban."},{"key":"B117","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3389\/fped.2019.00423","article-title":"Kawasaki disease complicated with macrophage activation syndrome: case reports and literature review","volume":"7","author":"Jin","year":"2019","journal-title":"Front Pediatr."},{"key":"B118","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s12098-015-1877-1","article-title":"Macrophage activation syndrome","volume":"83","author":"Sen","year":"2016","journal-title":"Indian J Pediatr."},{"key":"B119","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4049\/jimmunol.1701093","article-title":"IVIg promote cross-tolerance against inflammatory stimuli in vitro and in vivo.","volume":"201","author":"Dominguez-Soto","year":"2018","journal-title":"J Immunol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"5181","DOI":"10.4049\/jimmunol.1303375","article-title":"Intravenous immunoglobulin promotes antitumor responses by modulating macrophage polarization","volume":"193","author":"Dominguez-Soto","year":"2014","journal-title":"J Immunol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.3389\/fimmu.2018.02676","article-title":"IVIg and LPS co-stimulation induces IL-10 production by human monocytes, which is compromised by an FcgammaRIIA disease-associated gene variant","volume":"9","author":"Kozicky","year":"2018","journal-title":"Front Immunol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ajpath.2011.03.013","article-title":"Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis","volume":"179","author":"Narasaraju","year":"2011","journal-title":"Am J Pathol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1093\/infdis\/jix475","article-title":"High level of neutrophil extracellular traps correlates with poor prognosis of severe influenza a infection","volume":"217","author":"Zhu","year":"2018","journal-title":"J Infect Dis."},{"key":"B124","doi-asserted-by":"publisher","first-page":"e20200652","DOI":"10.1084\/jem.20200652","article-title":"Targeting potential drivers of COVID-19: neutrophil extracellular traps","volume":"217","author":"Barnes","year":"2020","journal-title":"J Exp Med."},{"key":"B125","doi-asserted-by":"publisher","first-page":"138999","DOI":"10.1101\/2020.04.30.20086736","article-title":"Neutrophil extracellular traps in COVID-19","volume":"5","author":"Zuo","year":"2020","journal-title":"JCI Insight."},{"key":"B126","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1067\/mpd.2002.127505","article-title":"Decreased nitric oxide production after intravenous immunoglobulin treatment in patients with Kawasaki disease","volume":"141","author":"Wang","year":"2002","journal-title":"J Pediatr."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1161\/CIRCRESAHA.112.266411","article-title":"Intravenous immunoglobulins modulate neutrophil activation and vascular injury through Fc\u03b3RIII and SHP-1","volume":"110","author":"Jang","year":"2012","journal-title":"Circul Res."},{"key":"B128","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1038\/s41598-017-01404-0","article-title":"IVIG regulates the survival of human but not mouse neutrophils","volume":"7","author":"Schneider","year":"2017","journal-title":"Sci Rep."},{"key":"B129","doi-asserted-by":"publisher","first-page":"104168","DOI":"10.1016\/j.phrs.2019.02.007","article-title":"Granulocyte death mediated by specific antibodies in intravenous immunoglobulin (IVIG)","volume":"154","author":"Graeter","year":"2019","journal-title":"Pharmacol Res."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14397595.2019.1602292","article-title":"Pharmaceutical immunoglobulins reduce neutrophil extracellular trap formation and ameliorate the development of MPO-ANCA-associated vasculitis","volume":"30","author":"Uozumi","year":"2019","journal-title":"Mod Rheumatol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41423-020-0402-2","article-title":"Functional exhaustion of antiviral lymphocytes in COVID-19 patients","volume":"17","author":"Zheng","year":"2020","journal-title":"Cell Mol Immunol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1309\/WPK7Y2XKNF4CBF3R","article-title":"The involvement of natural killer cells in the pathogenesis of severe acute respiratory syndrome","volume":"121","year":"2004","journal-title":"Am J Clin Pathol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3390\/v11030243","article-title":"Viral infection of human natural killer cells","volume":"11","author":"van Erp","year":"2019","journal-title":"Viruses."},{"key":"B134","doi-asserted-by":"publisher","first-page":"9215","DOI":"10.1128\/JVI.00805-09","article-title":"Influenza virus directly infects human natural killer cells and induces cell apoptosis","volume":"83","author":"Mao","year":"2009","journal-title":"J Virol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1111\/j.1468-1331.2010.03333.x","article-title":"The effect of IgG levels on the number of natural killer cells and their Fc receptors in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"18","author":"Bohn","year":"2011","journal-title":"Eur J Neurol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.clim.2015.11.005","article-title":"NK cell compartment in the peripheral blood and spleen in adult patients with primary immune thrombocytopenia","volume":"177","author":"Ebbo","year":"2017","journal-title":"Clin Immunol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"9428","DOI":"10.1002\/jcp.27627","article-title":"NK cell frequency and cytotoxicity in correlation to pregnancy outcome and response to IVIG therapy among women with recurrent pregnancy loss","volume":"234","author":"Ahmadi","year":"2019","journal-title":"J Cell Physiol."},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.04.001","article-title":"Effect of intravenous immunoglobulin G therapy on natural killer cell function related to Fc gamma receptor gene expression","author":"Papaserafeim","year":"2020","journal-title":"J Allergy Clin Immunol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir Med."},{"key":"B140","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.jmii.2020.03.005","article-title":"TH17 responses in cytokine storm of COVID-19: an emerging target of JAK2 inhibitor Fedratinib","volume":"53","author":"Wu","year":"2020","journal-title":"J Microbiol Immunol Infect."},{"key":"B141","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1365-2249.2004.02415.x","article-title":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome","volume":"136","author":"Wong","year":"2004","journal-title":"Clin Exp Immunol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cyto.2018.01.025","article-title":"MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile","volume":"104","year":"2018","journal-title":"Cytokine."},{"key":"B143","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1097\/MCC.0000000000000638","article-title":"Severe influenza: overview in critically ill patients","volume":"25","author":"Sarda","year":"2019","journal-title":"Curr Opin Crit Care."},{"key":"B144","doi-asserted-by":"publisher","first-page":"R201","DOI":"10.1186\/cc8208","article-title":"Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza","volume":"13","author":"Bermejo-Martin","year":"2009","journal-title":"Crit Care."},{"key":"B145","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1600-0897.2007.00506.x","article-title":"Elevated Th1\/Th2 cell ratios in a pregnant woman with a history of RSA, secondary Sjogren's syndrome and rheumatoid arthritis complicated with one fetal demise of twin pregnancy","volume":"58","author":"Kwak-Kim","year":"2007","journal-title":"Am J Reprod Immunol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1002\/art.37815","article-title":"Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1\/Th2 cytokine profiles in patients with Kawasaki disease","volume":"65","author":"Wang","year":"2013","journal-title":"Arthritis Rheum."},{"key":"B147","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1034\/j.1600-0897.2003.01169.x","article-title":"Effect of intravenous immunoglobulin treatment on the Th1\/Th2 balance in women with recurrent spontaneous abortions","volume":"49","author":"Graphou","year":"2003","journal-title":"Am J Reprod Immunol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1182\/blood.V100.5.1774.h81702001774_1774_1779","article-title":"Expression patterns of Th1 and Th2 cytokine genes in childhood idiopathic thrombocytopenic purpura (ITP) at presentation and their modulation by intravenous immunoglobulin G (IVIg) treatment: their role in prognosis","volume":"100","author":"Mouzaki","year":"2002","journal-title":"Blood."},{"key":"B149","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.biopha.2017.06.001","article-title":"Effect of Intravenous immunoglobulin on Th1 and Th2 lymphocytes and improvement of pregnancy outcome in recurrent pregnancy loss (RPL)","volume":"92","author":"Ahmadi","year":"2017","journal-title":"Biomed Pharmacother."},{"key":"B150","doi-asserted-by":"publisher","first-page":"5424","DOI":"10.1002\/jcb.27821","article-title":"Intravenous immunoglobulin G treatment increases live birth rate in women with recurrent miscarriage and modulates regulatory and exhausted regulatory T cells frequency and function","volume":"120","author":"Jafarzadeh","year":"2019","journal-title":"J Cell Biochem."},{"key":"B151","doi-asserted-by":"publisher","first-page":"e13018","DOI":"10.1111\/aji.13018","article-title":"Modulatory effect of intravenous immunoglobulin on Th17\/Treg cell balance in women with unexplained recurrent spontaneous abortion","volume":"80","author":"Muyayalo","year":"2018","journal-title":"Am J Reprod Immunol."},{"key":"B152","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.imlet.2017.10.003","article-title":"Intravenous immunoglobulin (IVIG) treatment modulates peripheral blood Th17 and regulatory T cells in recurrent miscarriage patients: non randomized, open-label clinical trial","volume":"192","author":"Ahmadi","year":"2017","journal-title":"Immunol Lett."},{"key":"B153","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1080\/19396368.2017.1390007","article-title":"Regulatory T cells improve pregnancy rate in RIF patients after additional IVIG treatment","volume":"63","author":"Ahmadi","year":"2017","journal-title":"Syst Biol Reprod Med."},{"key":"B154","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/all.12558","article-title":"Th17- and Treg-related cytokine and mRNA expression are associated with acute and resolving Kawasaki disease","volume":"70","author":"Guo","year":"2015","journal-title":"Allergy."},{"key":"B155","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s12026-014-8580-6","article-title":"Intravenous immunoglobulin exerts reciprocal regulation of Th1\/Th17 cells and regulatory T cells in Guillain-Barre syndrome patients","volume":"60","author":"Maddur","year":"2014","journal-title":"Immunol Res."},{"key":"B156","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/2045-7022-4-38","article-title":"High-dose intravenous immunoglobulin therapy for eosinophilic granulomatosis with polyangiitis","volume":"4","author":"Tsurikisawa","year":"2014","journal-title":"Clin Transl Allergy."},{"key":"B157","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1002\/eji.201444440","article-title":"Sialylation may be dispensable for reciprocal modulation of helper T cells by intravenous immunoglobulin","volume":"44","author":"Othy","year":"2014","journal-title":"Eur J Immunol."},{"key":"B158","doi-asserted-by":"publisher","first-page":"4535","DOI":"10.4049\/jimmunol.1201965","article-title":"Intravenous gammaglobulin inhibits encephalitogenic potential of pathogenic T cells and interferes with their trafficking to the central nervous system, implicating sphingosine-1 phosphate receptor 1-mammalian target of rapamycin axis","volume":"190","author":"Othy","year":"2013","journal-title":"J Immunol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3389\/fimmu.2017.00275","article-title":"Monomeric immunoglobulin a from plasma inhibits human th17 responses in vitro independent of FcalphaRI and DC-SIGN.","volume":"8","author":"Saha","year":"2017","journal-title":"Front Immunol."},{"key":"B160","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1016\/j.jaci.2012.02.050","article-title":"Intravenous immunoglobulin attenuates airway inflammation through induction of forkhead box protein 3-positive regulatory T cells","volume":"129","author":"Massoud","year":"2012","journal-title":"J Allergy Clin Immunol."},{"key":"B161","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1182\/blood-2012-11-468264","article-title":"Intravenous immunoglobulin expands regulatory T cells via induction of cyclooxygenase-2-dependent prostaglandin E2 in human dendritic cells","volume":"122","author":"Trinath","year":"2013","journal-title":"Blood."},{"key":"B162","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1002\/art.38082","article-title":"Contrasting mechanisms of interferon-alpha inhibition by intravenous immunoglobulin after induction by immune complexes versus Toll-like receptor agonists","volume":"65","author":"Wiedeman","year":"2013","journal-title":"Arthritis Rheum."},{"key":"B163","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.autrev.2012.08.017","article-title":"Tregitope update: mechanism of action parallels IVIg","volume":"12","author":"Cousens","year":"2013","journal-title":"Autoimmun Rev."},{"key":"B164","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1097\/ACI.0000000000000116","article-title":"Mechanisms of immune regulation by IVIG.","volume":"14","author":"Ballow","year":"2014","journal-title":"Curr Opin Allergy Clin Immunol."},{"key":"B165","doi-asserted-by":"publisher","first-page":"493138","DOI":"10.1155\/2013\/493138","article-title":"Tregitope peptides: the active pharmaceutical ingredient of IVIG?","volume":"2013","author":"De Groot","year":"2013","journal-title":"Clin Dev Immunol."},{"key":"B166","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00281-017-0636-y","article-title":"New fronts emerge in the influenza cytokine storm","volume":"39","author":"Guo","year":"2017","journal-title":"Semin Immunopathol."},{"key":"B167","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1128\/JVI.00464-14","article-title":"Animal model of respiratory syncytial virus: CD8+ T cells cause a cytokine storm that is chemically tractable by sphingosine-1-phosphate 1 receptor agonist therapy","volume":"88","author":"Walsh","year":"2014","journal-title":"J Virol."},{"key":"B168","doi-asserted-by":"publisher","first-page":"102437","DOI":"10.1016\/j.bcmd.2020.102437","article-title":"Increased expression of CD8 marker on T-cells in COVID-19 patients","volume":"83","author":"Ganji","year":"2020","journal-title":"Blood Cells Mol Dis."},{"key":"B169","doi-asserted-by":"publisher","first-page":"105954","DOI":"10.1016\/j.ijantimicag.2020.105954","article-title":"The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality","volume":"55","author":"Zhang","year":"2020","journal-title":"Int J Antimicrob Agents."},{"key":"B170","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.clim.2016.08.012","article-title":"Intravenous immunoglobulin treatment responsiveness depends on the degree of CD8+ T cell activation in Kawasaki disease","volume":"171","author":"Ye","year":"2016","journal-title":"Clin Immunol."},{"key":"B171","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1212\/WNL.0b013e31827debad","article-title":"Recovery of the T-cell repertoire in CIDP by IV immunoglobulins","volume":"80","author":"Mausberg","year":"2013","journal-title":"Neurology."},{"key":"B172","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1182\/blood-2012-07-445007","article-title":"Intravenous immunoglobulin (IVIg) inhibits CD8 cytotoxic T-cell activation","volume":"120","author":"Trepanier","year":"2012","journal-title":"Blood."},{"key":"B173","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/imm.12189","article-title":"Intravenous immunoglobulin modulates the expansion and cytotoxicity of CD8+ T cells","volume":"141","author":"Tr\u00e9panier","year":"2014","journal-title":"Immunology."},{"key":"B174","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/j.1399-3038.2010.01129.x","article-title":"Exogenous immunoglobulin downregulates T-cell receptor signaling and cytokine production","volume":"23","author":"Tawfik","year":"2012","journal-title":"Pediatr Allergy Immunol."},{"key":"B175","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1172\/JCI118488","article-title":"Antibodies to a conserved region of HLA class I molecules, capable of modulating CD8 T cell-mediated function, are present in pooled normal immunoglobulin for therapeutic use","volume":"97","author":"Kaveri","year":"1996","journal-title":"J Clin Invest."},{"key":"B176","doi-asserted-by":"publisher","first-page":"a016295","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in inflammation, immunity, and disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harb Perspect Biol."},{"key":"B177","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/stem.5530130506","article-title":"Relationships between B cell cytokine production in secondary lymphoid follicles and apoptosis of germinal center B lymphocytes","volume":"13","author":"Pistoia","year":"1995","journal-title":"Stem Cells."},{"key":"B178","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1084\/jem.20170580","article-title":"B cell-derived IL-6 initiates spontaneous germinal center formation during systemic autoimmunity","volume":"214","author":"Arkatkar","year":"2017","journal-title":"J Exp Med."},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa248","article-title":"Dysregulation of immune response in patients with COVID-19 in Wuhan, China","author":"Qin","year":"2020","journal-title":"Clin Infect Dis"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.23.20039362","article-title":"Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing","author":"Wen","year":"2020","journal-title":"medRxiv [Preprint]."},{"key":"B181","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jaci.2020.04.013","article-title":"A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia","volume":"146","author":"Quinti","year":"2020","journal-title":"J Allergy Clin Immunol."},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1111\/pai.13263","article-title":"Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover","author":"Soresina","year":"2020","journal-title":"Pediatr Allergy Immunol"},{"key":"B183","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/art.38910","article-title":"Review: intravenous immunoglobulin and B cells: when the product regulates the producer","volume":"67","author":"Seite","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"B184","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jaut.2010.09.006","article-title":"Intravenous immunoglobulin induces proliferation and immunoglobulin synthesis from B cells of patients with common variable immunodeficiency: a mechanism underlying the beneficial effect of IVIg in primary immunodeficiencies","volume":"36","author":"Bayry","year":"2011","journal-title":"J Autoimmun."},{"key":"B185","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/icb.2009.36","article-title":"Intravenous immunoglobulin up-regulates the expression of the inhibitory FcgammaIIB receptor on B cells","volume":"87","author":"Nikolova","year":"2009","journal-title":"Immunol Cell Biol."},{"key":"B186","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.molimm.2017.03.006","article-title":"FcgammaRIIb expression on B cells is associated with treatment efficacy for acute rejection after kidney transplantation","volume":"85","author":"Jin","year":"2017","journal-title":"Mol Immunol."},{"key":"B187","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1182\/blood-2003-01-0023","article-title":"IVIg-mediated amelioration of murine ITP via FcgammaRIIB is independent of SHIP1, SHP-1, and Btk activity","volume":"102","author":"Crow","year":"2003","journal-title":"Blood."},{"key":"B188","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1067\/mai.2002.127284","article-title":"Suppression of IL-4- and CD40-induced B-lymphocyte activation by intravenous immunoglobulin is not mediated through the inhibitory IgG receptor FcgammaRIIb","volume":"110","author":"Zhuang","year":"2002","journal-title":"J Allergy Clin Immunol."},{"key":"B189","doi-asserted-by":"publisher","first-page":"9868","DOI":"10.1073\/pnas.1307864110","article-title":"General mechanism for modulating immunoglobulin effector function","volume":"110","author":"Sondermann","year":"2013","journal-title":"Proc Natl Acad Sci USA."},{"key":"B190","doi-asserted-by":"publisher","first-page":"E3544","DOI":"10.1073\/pnas.1310657110","article-title":"Crystal structure of sialylated IgG Fc: implications for the mechanism of intravenous immunoglobulin therapy","volume":"110","author":"Crispin","year":"2013","journal-title":"Proc Natl Acad Sci USA."},{"key":"B191","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1182\/blood-2009-12-261461","article-title":"IVIg modulates BCR signaling through CD22 and promotes apoptosis in mature human B lymphocytes","volume":"116","author":"Seite","year":"2010","journal-title":"Blood."},{"key":"B192","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1182\/blood-2010-06-289892","article-title":"Sialic acid-IVIg targeting CD22","volume":"116","author":"Blank","year":"2010","journal-title":"Blood."},{"key":"B193","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s10875-010-9469-3","article-title":"IVIg attenuates TLR-9 activation in B cells from SLE patients","volume":"31","author":"Kessel","year":"2011","journal-title":"J Clin Immunol."},{"key":"B194","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jaut.2011.05.014","article-title":"TLR9 responses of B cells are repressed by intravenous immunoglobulin through the recruitment of phosphatase","volume":"37","author":"S\u00e9it\u00e9","year":"2011","journal-title":"J Autoimmun."},{"key":"B195","doi-asserted-by":"publisher","first-page":"e2109","DOI":"10.1371\/journal.pone.0002109","article-title":"Prominent plasmacytosis following intravenous immunoglobulin correlates with clinical improvement in Guillain-Barr\u00e9 syndrome","volume":"3","author":"Mori","year":"2008","journal-title":"PloS ONE."},{"key":"B196","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/acn3.687","article-title":"IVIg-induced plasmablasts in patients with Guillain-Barre syndrome","volume":"6","author":"Brem","year":"2019","journal-title":"Ann Clin Transl Neurol."},{"key":"B197","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3389\/fimmu.2018.00597","article-title":"Modulation of dengue\/zika virus pathogenicity by antibody-dependent enhancement and strategies to protect against enhancement in zika virus infection","volume":"9","author":"Khandia","year":"2018","journal-title":"Front Immunol."},{"key":"B198","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.pharmthera.2005.03.006","article-title":"Ross River virus: molecular and cellular aspects of disease pathogenesis","volume":"107","author":"Rulli","year":"2005","journal-title":"Pharmacol Ther."},{"key":"B199","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/imr.12367","article-title":"Fc receptors in antibody-dependent enhancement of viral infections","volume":"268","author":"Taylor","year":"2015","journal-title":"Immunol Rev."},{"key":"B200","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jmv.20499","article-title":"Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals","volume":"78","author":"Zhang","year":"2006","journal-title":"J Med Virol."},{"key":"B201","volume-title":"Mechanism of antibody-dependent enhancement in severe acute respiratory syndrome coronavirus infection (dissertation)","author":"Leung","year":""},{"key":"B202","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1743-422X-11-82","article-title":"Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus","volume":"11","author":"Yip","year":"2014","journal-title":"Virol J."},{"key":"B203","doi-asserted-by":"publisher","first-page":"e02015","DOI":"10.1128\/JVI.02015-19","article-title":"Molecular mechanism for antibody-dependent enhancement of coronavirus entry","volume":"94","author":"Wan","year":"2020","journal-title":"J Virol."},{"key":"B204","doi-asserted-by":"publisher","first-page":"15194","DOI":"10.1073\/pnas.1821317116","article-title":"Antibody-dependent enhancement of influenza disease promoted by increase in hemagglutinin stem flexibility and virus fusion kinetics","volume":"116","author":"Winarski","year":"2019","journal-title":"Proc Natl Acad Sci USA."},{"key":"B205","doi-asserted-by":"publisher","first-page":"200ra114","DOI":"10.1126\/scitranslmed.3006366","article-title":"Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease","volume":"5","author":"Khurana","year":"2013","journal-title":"Sci Transl Med."},{"key":"B206","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3389\/fimmu.2019.00548","article-title":"Fc-Mediated antibody effector functions during respiratory syncytial virus infection and disease","volume":"10","author":"van Erp","year":"2019","journal-title":"Front Immunol."},{"key":"B207","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1093\/infdis\/jiy566","article-title":"Respiratory syncytial virus infects primary neonatal and adult natural killer cells and affects their antiviral effector function","volume":"219","author":"van Erp","year":"2019","journal-title":"J Infect Dis."},{"key":"B208","doi-asserted-by":"publisher","first-page":"e00851","DOI":"10.1128\/JVI.00851-17","article-title":"In vitro enhancement of respiratory syncytial virus infection by maternal antibodies does not explain disease severity in infants","volume":"91","author":"van Erp","year":"2017","journal-title":"J Virol."},{"key":"B209","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41577-020-0321-6","article-title":"The potential danger of suboptimal antibody responses in COVID-19","volume":"20","author":"Iwasaki","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B210","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.3389\/fmicb.2018.02991","article-title":"Viral-induced enhanced disease illness","volume":"9","author":"Smatti","year":"2018","journal-title":"Front Microbiol."},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1007\/s12250-020-00207-4","article-title":"Understanding SARS-CoV-2-mediated inflammatory responses: from mechanisms to potential therapeutic tools","author":"Fu","year":"2020","journal-title":"Virol Sin"},{"key":"B212","doi-asserted-by":"publisher","first-page":"102768","DOI":"10.1016\/j.ebiom.2020.102768","article-title":"Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development","volume":"55","author":"de Alwis","year":"2020","journal-title":"EBioMedicine"},{"key":"B213","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1046\/j.1365-2249.1998.00538.x","article-title":"Effective prophylaxis of influenza A virus pneumonia in mice by topical passive immunotherapy with polyvalent human immunoglobulins or F(ab')2 fragments","volume":"111","author":"Ramisse","year":"1998","journal-title":"Clin Exp Immunol."},{"key":"B214","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ebiom.2017.04.010","article-title":"Intravenous immunoglobulin protects against severe pandemic influenza infection","volume":"19","author":"Rockman","year":"2017","journal-title":"EBioMedicine."},{"key":"B215","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1128\/AAC.32.8.1269","article-title":"Topically administered immunoglobulin reduces pulmonary respiratory syncytial virus shedding in owl monkeys","volume":"32","author":"Hemming","year":"1988","journal-title":"Antimicrob Agents Chemother."},{"key":"B216","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1093\/infdis\/152.5.1083","article-title":"Studies of passive immunotherapy for infections of respiratory syncytial virus in the respiratory tract of a primate model","volume":"152","author":"Hemming","year":"1985","journal-title":"J Infect Dis."},{"key":"B217","doi-asserted-by":"publisher","first-page":"S470","DOI":"10.1093\/clinids\/12.Supplement_4.S470","article-title":"Immunoprophylaxis of infections with respiratory syncytial virus: observations and hypothesis","volume":"12","author":"Hemming","year":"1990","journal-title":"Rev Infect Dis."},{"key":"B218","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1128\/JVI.61.6.1851-1854.1987","article-title":"Effectiveness of topically administered neutralizing antibodies in experimental immunotherapy of respiratory syncytial virus infection in cotton rats","volume":"61","author":"Prince","year":"1987","journal-title":"J Virol."},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.03.044","article-title":"Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19","author":"Xie","year":"2020","journal-title":"J Infect"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1101\/2020.02.17.20024166","article-title":"Clinical features and progression of acute respiratory distress syndrome in coronavirus disease 2019","author":"Liu","year":"2020","journal-title":"medRxiv [Preprint]"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.20944\/preprints202003.0065.v1","article-title":"Short-term moderate-dose corticosteroid plus immunoglobulin effectively reverses COVID-19 patients who have failed low-dose therapy","author":"Zhou","year":"2020","journal-title":"Preprints"},{"key":"B222","first-page":"826","article-title":"[Intravenous Immunoglobulin as adjunction treatment in treating 23 severe infectious atypical pneumonia patients]","volume":"26","author":"Wu","year":"2005","journal-title":"Jo Jinan Univ."},{"key":"B223","doi-asserted-by":"publisher","first-page":"818","DOI":"10.3201\/eid1005.030640","article-title":"Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients","volume":"10","author":"Wang","year":"2004","journal-title":"Emerg Infect Dis."},{"key":"B224","first-page":"21","article-title":"[Clinical analysis of intravenous immunoglobulin in children with severe acute respiratory syndrome]","author":"Zeng","year":"2003","journal-title":"Lin Chuang Er Ke Za Zhi."},{"key":"B225","first-page":"1173","article-title":"Pentaglobin in steroid-resistant severe acute respiratory syndrome","volume":"8","author":"Ho","year":"2004","journal-title":"Int J Tuberc Lung Dis."},{"key":"B226","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1093\/cid\/ciu635","article-title":"Clinical and laboratory findings of the first imported case of Middle East respiratory syndrome coronavirus to the United States","volume":"59","author":"Kapoor","year":"2014","journal-title":"Clin Infect Dis."},{"key":"B227","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1378\/chest.12-2907","article-title":"Hyperimmune IV immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A(H1N1) infection","volume":"144","author":"Hung","year":"2013","journal-title":"Chest."},{"key":"B228","first-page":"1729","article-title":"[High-dose intravenous immunoglobulin for children with severe H1N1 influenza infection]","author":"Lifeng","year":"2010","journal-title":"Int Med Health Guidance News."},{"key":"B229","first-page":"2171","article-title":"[Clinical observation on intravenous therapy with human immunoglobulin in severe H1N1 influenza in children]","author":"CHEN","year":"2013","journal-title":"Int Med Health Guidance News."},{"key":"B230","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1038\/bmt.2013.94","article-title":"Risk factors and containment of respiratory syncytial virus outbreak in a hematology and transplant unit","volume":"48","author":"Lehners","year":"2013","journal-title":"Bone Marrow Transplant."},{"key":"B231","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jinf.2019.04.004","article-title":"Treatment stratification of respiratory syncytial virus infection in allogeneic stem cell transplantation","volume":"78","author":"Balassa","year":"2019","journal-title":"J Infect."},{"key":"B232","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/sj.bmt.1702228","article-title":"Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin","volume":"25","author":"Ghosh","year":"2000","journal-title":"Bone Marrow Transplant."},{"key":"B233","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s10096-005-0004-z","article-title":"Treatment of severe acute respiratory syndrome","volume":"24","author":"Lai","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"B234","doi-asserted-by":"publisher","first-page":"e343","DOI":"10.1371\/journal.pmed.0030343","article-title":"SARS: systematic review of treatment effects","volume":"3","author":"Stockman","year":"2006","journal-title":"PLoS Med."},{"key":"B235","first-page":"301","article-title":"Effects of pentoxifyllin and pentaglobinO on TNF and IL-6 production in septic patients","volume":"42","author":"M\u00e1ndi","year":"1995","journal-title":"Acta Microbiol Immunol Hung."},{"key":"B236","doi-asserted-by":"publisher","first-page":"389","DOI":"10.7326\/M13-2486","article-title":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection","volume":"160","author":"Arabi","year":"2014","journal-title":"Ann Intern Med."},{"key":"B237","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/cmi.2015.74","article-title":"The cytokine storm of severe influenza and development of immunomodulatory therapy","volume":"13","author":"Liu","year":"2016","journal-title":"Cell Mol Immunol."},{"key":"B238","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1080\/17476348.2017.1338567","article-title":"Respiratory syncytial virus: prospects for new and emerging therapeutics","volume":"11","author":"Jorquera","year":"2017","journal-title":"Expert Rev Respir Med."},{"key":"B239","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1182\/blood-2010-08-263400","article-title":"Management of RSV infections in adult recipients of hematopoietic stem cell transplantation","volume":"117","author":"Shah","year":"2011","journal-title":"Blood."},{"key":"B240","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1093\/jac\/dkt111","article-title":"Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections","volume":"68","author":"Shah","year":"2013","journal-title":"J Antimicrob Chemother."},{"key":"B241","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/cid\/cis844","article-title":"Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirus","volume":"56","author":"Hirsch","year":"2013","journal-title":"Clin Infect Dis."},{"key":"B242","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jhin.2016.11.012","article-title":"Effective use of oral ribavirin for respiratory syncytial viral infections in allogeneic haematopoietic stem cell transplant recipients","volume":"95","author":"Gorcea","year":"2017","journal-title":"J Hosp Infect."},{"key":"B243","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ejca.2016.08.015","article-title":"Community acquired respiratory virus infections in cancer patients-Guideline on diagnosis and management by the Infectious Diseases Working Party of the German Society for haematology and Medical Oncology","volume":"67","author":"von","year":"2016","journal-title":"Eur J Cancer."},{"key":"B244","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.3389\/fimmu.2018.01299","article-title":"Adverse effects of immunoglobulin therapy","volume":"9","author":"Guo","year":"2018","journal-title":"Front Immunol."},{"key":"B245","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1016\/j.jacc.2020.04.031","article-title":"COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up","volume":"75","author":"Bikdeli","year":"2020","journal-title":"J Am Coll Cardiol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01660\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T06:42:53Z","timestamp":1594708973000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01660\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,14]]},"references-count":245,"alternative-id":["10.3389\/fimmu.2020.01660"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.01660","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,14]]},"article-number":"1660"}}